Shunji Endo
12PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jan 21, 2026
Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902).Shunji Endo, Ryo Tanaka, Toshifumi Yamaguchi
|Jan 11, 2026
Consensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome.Tomotaka Ueno, Toshio Takayama, Saya Chiba
|Jan 06, 2026
Management of Median Arcuate Ligament Compression in Patients Undergoing Pancreaticoduodenectomy: A Systematic Review and Consensus Statements.Noboru Ideno, Naoki Ikenaga, Yasunaru Sakuma
|Dec 19, 2025
Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting.Hidenori Haruta, Masaharu Higashida, Katsuyuki Hoshina
|Oct 17, 2025
Laparoscopic surgery for median arcuate ligament syndrome: How to do it.Masaharu Higashida, Shunji Endo, Masaaki Hori
|Nov 26, 2022
Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease.Hisato Kawakami, Kazuhiro Nishikawa, Toshio Shimokawa
Pageof 2
